Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
US7749725B2 · kind B2 · utility
0Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2002 |
| Grant date | Jul 6, 2010 |
| Priority date | — |
| Expiry date | Jul 7, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/86
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.